Quarterly guidance

Q4 Reported Revenue
$1.98 billion to $2 billion
Q4 Core Growth
5.2% to 6.2%
Q4 EPS
$1.71 to $1.74

Annual guidance

Full Year Reported Revenue
$7.49 billion to $7.51 billion
Full Year Core Growth
5.8% to 6%
Full Year EPS
$6.18 to $6.21 including tariff refunds, or $6.12 to $6.15 excluding refunds

Outlook

End markets
Broadest end markets continue to improve, led by pharma and applied markets.
Specialty CDMO
Expected to be flattish in Q4 due to regulatory submission timings, with mid-teens long-range growth.
China demand
Momentum in China is expected to continue into year-end.
Inflation and costs
Middle East conflict and memory chip demand continue to pressure costs, but the Ignite Operating System is expected to absorb inflationary impacts.